Marshall Wace »

Lineage Cell Therapeutics In shares owned by Marshall Wace

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3M 1.4M 1.67
2023-03-31 $84k 56k 1.50
2022-12-31 $43k 37k 1.17
2022-09-30 $50k 44k 1.14
2021-06-30 $533k 187k 2.85

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Vanguard S&p 500 Etp (VOO)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-a Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Adv Micro Device Equity Option Call Option (AMD)
Meta Platforms-a Common Stock (META)
Walmart Common Stock (WMT)
Tesla Common Stock (TSLA)
Alphabet Inc-c Common Stock (GOOG)
Circle Internet Common Stock (CRCL)

View all positions for Marshall Wace

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Defender Capital
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
Goldman Sachs Group
Marshall Wace
State Street Corporation
Red Crane Wealth Management
Northern Trust

View all funds holding Lineage Cell Therapeutics In